Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth.

Abstract

Lung cancer is the leading cause of cancer death worldwide. Small-cell lung cancer (SCLC) is an aggressive type of lung cancer that shows an overall 5-year survival rate below 10%. Although chemotherapy using cisplatin has been proven effective in SCLC treatment, conventional dose of cisplatin causes adverse side effects. Photodynamic therapy, a form of non… (More)
DOI: 10.1016/j.bbrc.2017.04.089

Topics

Cite this paper

@article{Cheng2017CisplatinAP, title={Cisplatin and photodynamic therapy exert synergistic inhibitory effects on small-cell lung cancer cell viability and xenograft tumor growth.}, author={You-Shuang Cheng and Yin-Bo Peng and Min Li Yao and Ji-Ping Teng and Da Ni and Zhijun Zhu and Bu-Feng Zhuang and Zhi-Yin Yang}, journal={Biochemical and biophysical research communications}, year={2017}, volume={487 3}, pages={567-572} }